Kamada (KMDA) Exchange Rate Effect (2013 - 2026)
Kamada (KMDA) reported Exchange Rate Effect of -$202000.0 for Q1 2026, down 349.38% on a YoY basis from $81000.0 in Q1 2025, and down 44.29% quarter-over-quarter from -$140000.0 in Q4 2025.
Kamada (KMDA) Exchange Rate Effect (2013 - 2026) Analysis & Trends
Kamada has reported Exchange Rate Effect for 14 years, with the latest figure at -$202000.0 in Q1 2026.
- For the quarter ending Q1 2026, Exchange Rate Effect fell 349.38% year-over-year to -$202000.0; the trailing twelve-month figure through Mar 2026 stood at -$556000.0 (down 2317.39% YoY), and the FY2025 full-year result was -$273000.0, down 82.0% from the prior year.
- Exchange Rate Effect for Q1 2026 stood at -$202000.0, down from -$140000.0 in the prior quarter.
- The five-year high for Exchange Rate Effect was $482000.0 in Q4 2023, with the low at -$332000.0 in Q4 2024.
- Historically, Exchange Rate Effect has averaged $26140.7 across 5 years, with a median of -$296.0 in 2022.
- Annual changes were most pronounced in 2023 — Exchange Rate Effect jumped 110910.81% — and 2024, when it plunged 14643.59%.
- Kamada's Exchange Rate Effect stood at $112000.0 in 2022, then surged by 330.36% to $482000.0 in 2023, then sank by 168.88% to -$332000.0 in 2024, then jumped by 57.83% to -$140000.0 in 2025, then plunged by 44.29% to -$202000.0 in 2026.
- The last three Exchange Rate Effect figures came in at -$202000.0 (Q1 2026), -$140000.0 (Q4 2025), and -$61000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -17.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 17.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -5.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -2.38 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -22,000.00 |
| 10 | Kamada | 504.70 | -73.15 Mn | 19.12 Mn | -202,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -202,000.00 |
| Mar 31, 2026 | -202,000.00 |
| Dec 31, 2025 | -140,000.00 |
| Dec 31, 2025 | -140,000.00 |
| Sep 30, 2025 | -61,000.00 |
| Sep 30, 2025 | -61,000.00 |
| Jun 30, 2025 | -153,000.00 |
| Jun 30, 2025 | -153,000.00 |
| Mar 31, 2025 | 81,000.00 |
| Mar 31, 2025 | 81,000.00 |
| Dec 31, 2024 | -332,000.00 |
| Dec 31, 2024 | -332,000.00 |
| Sep 30, 2024 | 151,000.00 |
| Sep 30, 2024 | 151,000.00 |
| Jun 30, 2024 | 77,000.00 |
| Jun 30, 2024 | 77,000.00 |
| Mar 31, 2024 | -46,000.00 |
| Mar 31, 2024 | -46,000.00 |
| Dec 31, 2023 | 482,000.00 |
| Dec 31, 2023 | 482,000.00 |